• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝纤维化中肝细胞的炎性小体和细胞焦亡。

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis.

机构信息

Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.

Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Immunol. 2022 May 30;13:896473. doi: 10.3389/fimmu.2022.896473. eCollection 2022.

DOI:10.3389/fimmu.2022.896473
PMID:35707547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9189314/
Abstract

Inflammasomes are multiprotein complexes that can sense danger signals and activate caspase-1 to mediate pro-inflammatory cytokines release and pyroptotic cell death. There are two main canonical and non-canonical signaling pathways that trigger inflammasome activation. Inflammasomes are expressed and assembled in parenchymal and nonparenchymal cells in response to liver injury in the liver. Additionally, the hepatocytes, biliary epithelial cells (cholangiocytes), hepatic stellate cells (HSCs), hepatic macrophages, and liver sinusoidal endothelial cells (LSECs) contribute to liver fibrosis different mechanisms. However, the underlying mechanism of the inflammasome and pyroptosis in these liver cells in liver fibrosis remains elusive. This review summarizes the activation and function of inflammasome complexes and then discusses the association between inflammasomes, pyroptosis, and liver fibrosis. Unlike other similar reviewers, we will focus on the effect of inflammasome activation and pyroptosis in the various liver cells during the development of liver fibrosis. We will also highlight the latest progress of pharmacological intervention in inflammasome-mediated liver fibrosis.

摘要

炎症小体是一种多蛋白复合物,可以感知危险信号,并激活半胱氨酸天冬氨酸蛋白酶-1(caspase-1),从而介导促炎细胞因子的释放和细胞焦亡。有两种主要的经典和非经典信号通路可以触发炎症小体的激活。炎症小体在肝脏损伤时,在实质细胞和非实质细胞中表达和组装。此外,肝细胞、胆管上皮细胞(胆管细胞)、肝星状细胞(HSCs)、肝巨噬细胞和肝窦内皮细胞(LSECs)通过不同的机制参与肝纤维化。然而,炎症小体和细胞焦亡在肝纤维化这些肝细胞中的潜在机制仍不清楚。这篇综述总结了炎症小体复合物的激活和功能,然后讨论了炎症小体、细胞焦亡与肝纤维化之间的关系。与其他类似的综述不同,我们将重点关注炎症小体激活和细胞焦亡在肝纤维化发展过程中各种肝细胞中的作用。我们还将重点介绍炎症小体介导的肝纤维化的药理学干预的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/8c5d622cf884/fimmu-13-896473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/65e56e089538/fimmu-13-896473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/ee0954fd73c9/fimmu-13-896473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/8c5d622cf884/fimmu-13-896473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/65e56e089538/fimmu-13-896473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/ee0954fd73c9/fimmu-13-896473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cd2/9189314/8c5d622cf884/fimmu-13-896473-g003.jpg

相似文献

1
Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis.肝纤维化中肝细胞的炎性小体和细胞焦亡。
Front Immunol. 2022 May 30;13:896473. doi: 10.3389/fimmu.2022.896473. eCollection 2022.
2
Multi-faceted role of pyroptosis mediated by inflammasome in liver fibrosis.炎性小体介导热激细胞死亡在肝纤维化中的多效性作用。
J Cell Mol Med. 2022 May;26(10):2757-2765. doi: 10.1111/jcmm.17277. Epub 2022 Apr 12.
3
Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.细胞相互作用是炎症信号导致肝纤维化发展的结果。
Cells. 2020 Feb 18;9(2):461. doi: 10.3390/cells9020461.
4
Role of the Inflammasome in Liver Disease.炎症小体在肝脏疾病中的作用。
Annu Rev Pathol. 2022 Jan 24;17:345-365. doi: 10.1146/annurev-pathmechdis-032521-102529. Epub 2021 Nov 9.
5
An overview of the non-canonical inflammasome.非经典炎性小体概述。
Mol Aspects Med. 2020 Dec;76:100924. doi: 10.1016/j.mam.2020.100924. Epub 2020 Nov 11.
6
Hepatocytes Are Resistant to Cell Death From Canonical and Non-Canonical Inflammasome-Activated Pyroptosis.肝细胞对经典和非经典炎症小体激活的细胞焦亡有抗性。
Cell Mol Gastroenterol Hepatol. 2022;13(3):739-757. doi: 10.1016/j.jcmgh.2021.11.009. Epub 2021 Dec 7.
7
Inflammasomes in Liver Fibrosis.炎症小体与肝纤维化
Semin Liver Dis. 2017 May;37(2):119-127. doi: 10.1055/s-0037-1601350. Epub 2017 May 31.
8
Gossypol induces pyroptosis in mouse macrophages via a non-canonical inflammasome pathway.棉酚通过非经典炎性小体途径诱导小鼠巨噬细胞发生焦亡。
Toxicol Appl Pharmacol. 2016 Feb 1;292:56-64. doi: 10.1016/j.taap.2015.12.027. Epub 2016 Jan 4.
9
Mechanisms governing inflammasome activation, assembly and pyroptosis induction.调控炎症小体激活、组装和细胞焦亡诱导的机制。
Int Immunol. 2017 May 1;29(5):201-210. doi: 10.1093/intimm/dxx018.
10
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.脂肪酸和内毒素激活小鼠肝细胞中的炎性体,释放危险信号以刺激免疫细胞。
Hepatology. 2011 Jul;54(1):133-44. doi: 10.1002/hep.24341.

引用本文的文献

1
Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis.代谢功能障碍相关脂肪性肝病和肝纤维化中的花生四烯酸代谢
Hepatol Commun. 2025 Aug 29;9(9). doi: 10.1097/HC9.0000000000000802. eCollection 2025 Sep 1.
2
Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis.通过靶向细胞焦亡治疗肝纤维化/肝硬化的方法。
Open Life Sci. 2025 Jul 11;20(1):20251092. doi: 10.1515/biol-2025-1092. eCollection 2025.
3
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma.

本文引用的文献

1
Role of Immune Cells in Biliary Repair.免疫细胞在胆管修复中的作用。
Front Immunol. 2022 Mar 30;13:866040. doi: 10.3389/fimmu.2022.866040. eCollection 2022.
2
Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke.沉默调节蛋白-1介导的核因子-κB信号通路调节以减轻炎性小体信号传导和细胞凋亡是缺血性中风后动脉内间充质干细胞治疗的神经保护作用之一。
Stem Cell Rev Rep. 2022 Feb;18(2):821-838. doi: 10.1007/s12015-021-10315-7. Epub 2022 Feb 3.
3
Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease.
代谢功能障碍相关脂肪性肝病进展中的慢性炎症与免疫失调:从脂肪变性到肝细胞癌
Biomedicines. 2025 May 21;13(5):1260. doi: 10.3390/biomedicines13051260.
4
Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.肝窦稳态破坏导致肝肺综合征。
J Cell Mol Med. 2025 May;29(9):e70585. doi: 10.1111/jcmm.70585.
5
Mechanistic Studies on the Role of IL-17/NLRP3 in Arsenic-Induced Activation of Hepatic Stellate Cells Through Hepatocyte Proptosis.白细胞介素-17/核苷酸结合寡聚化结构域样受体蛋白3通过肝细胞凋亡在砷诱导肝星状细胞激活中的作用机制研究
Toxics. 2025 Apr 9;13(4):287. doi: 10.3390/toxics13040287.
6
Gut microbiota and HMGB1/NLRP3/GSDMD inflammasome-dependent pyroptosis: mechanisms by physcion ameliorates alcoholic liver fibrosis.肠道微生物群与HMGB1/NLRP3/GSDMD炎性小体依赖性细胞焦亡:大黄素改善酒精性肝纤维化的机制
Front Pharmacol. 2025 Mar 27;16:1532590. doi: 10.3389/fphar.2025.1532590. eCollection 2025.
7
Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation.簇集素缺乏通过内质网应激和NLRP3炎性小体激活加重胆汁淤积性肝病。
Cell Biosci. 2025 Mar 15;15(1):36. doi: 10.1186/s13578-025-01376-z.
8
Methamphetamine-mediated astrocytic pyroptosis and neuroinflammation involves miR-152-NLRP6 inflammasome signaling axis.甲基苯丙胺介导的星形胶质细胞焦亡和神经炎症涉及miR-152-NLRP6炎性小体信号轴。
Redox Biol. 2025 Mar;80:103517. doi: 10.1016/j.redox.2025.103517. Epub 2025 Jan 25.
9
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.pir-hsa-216911通过抑制TLR4启动的GSDMD激活来抑制肝细胞癌中的细胞焦亡。
Cell Death Discov. 2025 Jan 17;11(1):11. doi: 10.1038/s41420-024-02285-9.
10
Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models.酒精性肝病(ALD):关于发病机制、治疗策略及动物模型的当前观点
Front Pharmacol. 2024 Nov 28;15:1432480. doi: 10.3389/fphar.2024.1432480. eCollection 2024.
慢性肝病中组蛋白修饰的机制与治疗机遇
Front Pharmacol. 2021 Nov 23;12:784591. doi: 10.3389/fphar.2021.784591. eCollection 2021.
4
MCC950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function.MCC950通过调节巨噬细胞极化和髓源性抑制细胞功能改善急性肝损伤。
Front Med (Lausanne). 2021 Nov 19;8:752223. doi: 10.3389/fmed.2021.752223. eCollection 2021.
5
Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress.塞来昔布通过改善内皮氧化应激降低门静脉高压症肝血管阻力。
J Cell Mol Med. 2021 Nov;25(22):10389-10402. doi: 10.1111/jcmm.16968. Epub 2021 Oct 5.
6
Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases.环状 RNA 作为慢性肝病中的一种表观遗传调节剂。
Cells. 2021 Jul 30;10(8):1945. doi: 10.3390/cells10081945.
7
Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling.髓系Nrf2缺乏通过调节YAP介导的NLRP3炎性小体信号通路加重非酒精性脂肪性肝炎的进展。
iScience. 2021 Apr 16;24(5):102427. doi: 10.1016/j.isci.2021.102427. eCollection 2021 May 21.
8
Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome.全氟烷基物质污染物通过 AIM2 炎性小体激活先天免疫系统。
Nat Commun. 2021 May 18;12(1):2915. doi: 10.1038/s41467-021-23201-0.
9
Regulation and functional roles of chemokines in liver diseases.趋化因子在肝脏疾病中的调控作用和功能。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):630-647. doi: 10.1038/s41575-021-00444-2. Epub 2021 May 11.
10
Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.Caspase-11 介导的肝细胞细胞焦亡促进非酒精性脂肪性肝炎的进展。
Cell Mol Gastroenterol Hepatol. 2021;12(2):653-664. doi: 10.1016/j.jcmgh.2021.04.009. Epub 2021 Apr 21.